BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22755696)

  • 21. Mitigating SUV uncertainties using total body PET imaging.
    Smith CLC; Zwezerijnen GJC; den Hollander ME; Weijland J; Yaqub M; Boellaard R
    Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1070-1078. PubMed ID: 37953391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial volume correction and image segmentation for accurate measurement of standardized uptake value of grey matter in the brain.
    Bural G; Torigian D; Basu S; Houseni M; Zhuge Y; Rubello D; Udupa J; Alavi A
    Nucl Med Commun; 2015 Dec; 36(12):1249-52. PubMed ID: 26426967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A semi-automated technique determining the liver standardized uptake value reference for tumor delineation in FDG PET-CT.
    Hirata K; Kobayashi K; Wong KP; Manabe O; Surmak A; Tamaki N; Huang SC
    PLoS One; 2014; 9(8):e105682. PubMed ID: 25162396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjustment of vascular 2-deoxy-2-[
    Kafouris PP; Koutagiar IP; Georgakopoulos AT; Pianou NK; Metaxas MG; Spyrou GM; Anagnostopoulos CD
    Int J Cardiovasc Imaging; 2019 May; 35(5):955-964. PubMed ID: 30706352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computer-aided detection and segmentation of malignant melanoma lesions on whole-body
    Dirks I; Keyaerts M; Neyns B; Vandemeulebroucke J
    Comput Methods Programs Biomed; 2022 Jun; 221():106902. PubMed ID: 35636357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study.
    Lyons K; Seghers V; Sorensen JI; Zhang W; Paldino MJ; Krishnamurthy R; Rohren EM
    AJR Am J Roentgenol; 2015 Nov; 205(5):1094-101. PubMed ID: 26496558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Test-Retest Variability in Lesion SUV and Lesion SUR in
    Hofheinz F; Apostolova I; Oehme L; Kotzerke J; van den Hoff J
    J Nucl Med; 2017 Nov; 58(11):1770-1775. PubMed ID: 28473598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
    Minamimoto R; Mosci C; Jamali M; Barkhodari A; Habte F; Jackson T; Mittra E; Gambhir SS; Iagaru A
    J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors.
    Huang YE; Chen CF; Huang YJ; Konda SD; Appelbaum DE; Pu Y
    Acta Radiol; 2010 Sep; 51(7):782-8. PubMed ID: 20707663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT.
    Wang R; Zhu H; Chen Y; Li C; Li F; Shen Z; Tian J; Yu L; Xu B
    Hematol Oncol; 2014 Sep; 32(3):126-32. PubMed ID: 23996464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of manual and automated approaches for segmentation and extraction of quantitative indices from [
    Krokos G; Kotwal T; Malaih A; Barrington S; Jackson P; Hicks RJ; Marsden PK; Fischer BM
    Biomed Phys Eng Express; 2024 Jan; 10(2):. PubMed ID: 38100790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of automated whole-body analysis of metabolic and morphological parameters from an integrated FDG-PET/MRI acquisition.
    Guglielmo P; Ekström S; Strand R; Visvanathar R; Malmberg F; Johansson E; Pereira MJ; Skrtic S; Carlsson BCL; Eriksson JW; Ahlström H; Kullberg J
    Sci Rep; 2020 Mar; 10(1):5331. PubMed ID: 32210327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Validation of standardized uptake values for ¹⁸F-FDG in normal organs: comparison of whole-body PET/CT and PET/MRI].
    Fu L; Liu J; Yin D; Zhang J; Chen Y; An N; Xu B; Tian J
    Zhonghua Yi Xue Za Zhi; 2014 Oct; 94(37):2934-7. PubMed ID: 25549648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Test-Retest Reproducibility of
    Kurland BF; Peterson LM; Shields AT; Lee JH; Byrd DW; Novakova-Jiresova A; Muzi M; Specht JM; Mankoff DA; Linden HM; Kinahan PE
    J Nucl Med; 2019 May; 60(5):608-614. PubMed ID: 30361381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical feasibility and impact of fully automated multiparametric PET imaging using direct Patlak reconstruction: evaluation of 103 dynamic whole-body
    Dias AH; Pedersen MF; Danielsen H; Munk OL; Gormsen LC
    Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):837-850. PubMed ID: 32894338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of liver SUV using unenhanced CT versus contrast-enhanced CT for attenuation correction in (18)F-FDG PET/CT.
    ter Voert EE; van Laarhoven HW; Kok PJ; Oyen WJ; Visser EP; de Geus-Oei LF
    Nucl Med Commun; 2014 May; 35(5):472-7. PubMed ID: 24509519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.